Plasma Protease C1-inhibitor Treatment Market Report

Global and China Plasma Protease C1-inhibitor Treatment Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 10, 2022
  • PAGES：176
  • REPORT CODE：GMM1452259
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Plasma Protease C1-inhibitor Treatment industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Takeda Pharmaceutical Company Limited

    • BioCryst Pharmaceuticals

    • Ionis Pharmaceuticals, Inc

    • Centogene AG

    • CSL Behring LLC

    • KalVista Pharmaceuticals, Inc

    • Pharming Technologies BV

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • C1-inhibitors

    • Kallikrein Inhibitor (Kalbitor)

    Application:

    • Hospital Pharmacies

    • Independent Pharmacies and Outlets

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Plasma Protease C1-inhibitor Treatment Industry Overview

      • 1.1.1 Plasma Protease C1-inhibitor Treatment Market Scope and Market Segments

      • 1.1.2 Plasma Protease C1-inhibitor Treatment Industry Characteristics

      • 1.1.3 Global and China Plasma Protease C1-inhibitor Treatment Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Plasma Protease C1-inhibitor Treatment Production Value and Growth Rate (2017-2028)

    • 1.2 Global Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 C1-inhibitors

      • 1.2.2 Kallikrein Inhibitor (Kalbitor)

    • 1.3 Global Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital Pharmacies

      • 1.3.2 Independent Pharmacies and Outlets

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Plasma Protease C1-inhibitor Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Plasma Protease C1-inhibitor Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Plasma Protease C1-inhibitor Treatment Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Plasma Protease C1-inhibitor Treatment Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Plasma Protease C1-inhibitor Treatment Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Plasma Protease C1-inhibitor Treatment Industry Porter's Five Forces Model Analysis

      • 2.2.3 Plasma Protease C1-inhibitor Treatment Industry PEST Analysis

    • 2.3 Plasma Protease C1-inhibitor Treatment Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Plasma Protease C1-inhibitor Treatment Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Plasma Protease C1-inhibitor Treatment Industry

    Chapter 3 Global and China Plasma Protease C1-inhibitor Treatment Market, by Manufacturer

    • 3.1 Global and China Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Plasma Protease C1-inhibitor Treatment Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Plasma Protease C1-inhibitor Treatment Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Plasma Protease C1-inhibitor Treatment Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Plasma Protease C1-inhibitor Treatment Market Top 3 Players

    Chapter 4 Global and China Plasma Protease C1-inhibitor Treatment Market, by Type (2017-2028)

    • 4.1 Plasma Protease C1-inhibitor Treatment Market Trend, by Type

    • 4.2 Global Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Plasma Protease C1-inhibitor Treatment Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Plasma Protease C1-inhibitor Treatment Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Plasma Protease C1-inhibitor Treatment Price Trend, by Type (2017-2028)

    • 4.3 China Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Plasma Protease C1-inhibitor Treatment Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Plasma Protease C1-inhibitor Treatment Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Plasma Protease C1-inhibitor Treatment Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Plasma Protease C1-inhibitor Treatment Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Plasma Protease C1-inhibitor Treatment Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Plasma Protease C1-inhibitor Treatment Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Plasma Protease C1-inhibitor Treatment Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Plasma Protease C1-inhibitor Treatment Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Plasma Protease C1-inhibitor Treatment Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Plasma Protease C1-inhibitor Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Plasma Protease C1-inhibitor Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Plasma Protease C1-inhibitor Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Plasma Protease C1-inhibitor Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Plasma Protease C1-inhibitor Treatment Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Plasma Protease C1-inhibitor Treatment Market Analysis

    • 7.1 North America Plasma Protease C1-inhibitor Treatment Market, by Type

    • 7.2 North America Plasma Protease C1-inhibitor Treatment Market, by Application

    • 7.3 North America Plasma Protease C1-inhibitor Treatment Market Analysis and Forecast, by Country

      • 7.3.1 United States Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Plasma Protease C1-inhibitor Treatment Market Analysis

    • 8.1 Europe Plasma Protease C1-inhibitor Treatment Market, by Type

    • 8.2 Europe Plasma Protease C1-inhibitor Treatment Market, by Application

    • 8.3 Europe Plasma Protease C1-inhibitor Treatment Market Analysis and Forecast, by Country

      • 8.3.1 Germany Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Plasma Protease C1-inhibitor Treatment Market Analysis

    • 9.1 APAC Plasma Protease C1-inhibitor Treatment Market, by Type

    • 9.2 APAC Plasma Protease C1-inhibitor Treatment Market, by Application

    • 9.3 APAC Plasma Protease C1-inhibitor Treatment Market Analysis and Forecast, by Country

      • 9.3.1 China Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Plasma Protease C1-inhibitor Treatment Market Analysis

    • 10.1 Latin America, Middle East and Africa Plasma Protease C1-inhibitor Treatment Market, by Type

    • 10.2 Latin America, Middle East and Africa Plasma Protease C1-inhibitor Treatment Market, by Application

    • 10.3 Latin America, Middle East and Africa Plasma Protease C1-inhibitor Treatment Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Plasma Protease C1-inhibitor Treatment Company Profiles

      • 11.1 Takeda Pharmaceutical Company Limited

        • 11.1.1 Takeda Pharmaceutical Company Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Takeda Pharmaceutical Company Limited Plasma Protease C1-inhibitor Treatment Product Profiles, Application and Specification

        • 11.1.3 Takeda Pharmaceutical Company Limited Plasma Protease C1-inhibitor Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 BioCryst Pharmaceuticals

        • 11.2.1 BioCryst Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 BioCryst Pharmaceuticals Plasma Protease C1-inhibitor Treatment Product Profiles, Application and Specification

        • 11.2.3 BioCryst Pharmaceuticals Plasma Protease C1-inhibitor Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Ionis Pharmaceuticals, Inc

        • 11.3.1 Ionis Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Ionis Pharmaceuticals, Inc Plasma Protease C1-inhibitor Treatment Product Profiles, Application and Specification

        • 11.3.3 Ionis Pharmaceuticals, Inc Plasma Protease C1-inhibitor Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Centogene AG

        • 11.4.1 Centogene AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Centogene AG Plasma Protease C1-inhibitor Treatment Product Profiles, Application and Specification

        • 11.4.3 Centogene AG Plasma Protease C1-inhibitor Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 CSL Behring LLC

        • 11.5.1 CSL Behring LLC Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 CSL Behring LLC Plasma Protease C1-inhibitor Treatment Product Profiles, Application and Specification

        • 11.5.3 CSL Behring LLC Plasma Protease C1-inhibitor Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 KalVista Pharmaceuticals, Inc

        • 11.6.1 KalVista Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 KalVista Pharmaceuticals, Inc Plasma Protease C1-inhibitor Treatment Product Profiles, Application and Specification

        • 11.6.3 KalVista Pharmaceuticals, Inc Plasma Protease C1-inhibitor Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Pharming Technologies BV

        • 11.7.1 Pharming Technologies BV Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Pharming Technologies BV Plasma Protease C1-inhibitor Treatment Product Profiles, Application and Specification

        • 11.7.3 Pharming Technologies BV Plasma Protease C1-inhibitor Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Plasma Protease C1-inhibitor Treatment Industry Investment Prospect and Risk Assessment

    • 12.1 Plasma Protease C1-inhibitor Treatment Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Plasma Protease C1-inhibitor Treatment Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Plasma Protease C1-inhibitor Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure China Plasma Protease C1-inhibitor Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Global Plasma Protease C1-inhibitor Treatment Production Value and Growth Rate (2017-2028)

    • Figure China Plasma Protease C1-inhibitor Treatment Production Value and Growth Rate (2017-2028)

    • Figure Global Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate of C1-inhibitors (2017-2028)

    • Figure Global Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate of Kallikrein Inhibitor (Kalbitor) (2017-2028)

    • Figure Global Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate of Hospital Pharmacies (2017-2028)

    • Figure Global Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate of Independent Pharmacies and Outlets (2017-2028)

    • Figure North America Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Plasma Protease C1-inhibitor Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Plasma Protease C1-inhibitor Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Plasma Protease C1-inhibitor Treatment Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Plasma Protease C1-inhibitor Treatment Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Plasma Protease C1-inhibitor Treatment Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Plasma Protease C1-inhibitor Treatment Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Plasma Protease C1-inhibitor Treatment Market Share, by Manufacturer in 2021

    • Figure Global and China Plasma Protease C1-inhibitor Treatment Market Share, by Manufacturer in 2022

    • Table Global Plasma Protease C1-inhibitor Treatment Sales Volume, by Type (2017-2028)

    • Table Global Plasma Protease C1-inhibitor Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Global Plasma Protease C1-inhibitor Treatment Sales Volume Share, by Type (2017-2028)

    • Table Global Plasma Protease C1-inhibitor Treatment Sales Value, by Type (2017-2028)

    • Table Global Plasma Protease C1-inhibitor Treatment Sales Value Share, by Type (2017-2028)

    • Figure Global Plasma Protease C1-inhibitor Treatment Price Trend, by Type (2017-2028)

    • Table China Plasma Protease C1-inhibitor Treatment Sales Volume, by Type (2017-2028)

    • Table China Plasma Protease C1-inhibitor Treatment Sales Volume Share, by Type (2017-2028)

    • Figure China Plasma Protease C1-inhibitor Treatment Sales Volume Share, by Type (2017-2028)

    • Table China Plasma Protease C1-inhibitor Treatment Sales Value, by Type (2017-2028)

    • Table China Plasma Protease C1-inhibitor Treatment Sales Value Share, by Type (2017-2028)

    • Figure China Plasma Protease C1-inhibitor Treatment Price Trend, by Type (2017-2028)

    • Table Global Plasma Protease C1-inhibitor Treatment Sales Volume, by Application (2017-2028)

    • Table Global Plasma Protease C1-inhibitor Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Global Plasma Protease C1-inhibitor Treatment Sales Volume Share, by Application (2017-2028)

    • Table Global Plasma Protease C1-inhibitor Treatment Sales Value, by Application (2017-2028)

    • Table Global Plasma Protease C1-inhibitor Treatment Sales Value Share, by Application (2017-2028)

    • Figure Global Plasma Protease C1-inhibitor Treatment Sales Value Share, by Application (2017-2028)

    • Table China Plasma Protease C1-inhibitor Treatment Sales Volume, by Application (2017-2028)

    • Table China Plasma Protease C1-inhibitor Treatment Sales Volume Share, by Application (2017-2028)

    • Figure China Plasma Protease C1-inhibitor Treatment Sales Volume Share, by Application (2017-2028)

    • Table China Plasma Protease C1-inhibitor Treatment Sales Value, by Application (2017-2028)

    • Table China Plasma Protease C1-inhibitor Treatment Sales Value Share, by Application (2017-2028)

    • Figure China Plasma Protease C1-inhibitor Treatment Sales Value Share, by Application (2017-2028)

    • Figure China Plasma Protease C1-inhibitor Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure North America Plasma Protease C1-inhibitor Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Plasma Protease C1-inhibitor Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Plasma Protease C1-inhibitor Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Plasma Protease C1-inhibitor Treatment Production, Import, Consumption and Export (2017-2022)

    • Table North America Plasma Protease C1-inhibitor Treatment Sales Volume, by Type (2017-2028)

    • Table North America Plasma Protease C1-inhibitor Treatment Sales Volume Share, by Type (2017-2028)

    • Figure North America Plasma Protease C1-inhibitor Treatment Sales Volume Share, by Type (2017-2028)

    • Table North America Plasma Protease C1-inhibitor Treatment Sales Volume, by Application (2017-2028)

    • Table North America Plasma Protease C1-inhibitor Treatment Sales Volume Share, by Application (2017-2028)

    • Figure North America Plasma Protease C1-inhibitor Treatment Sales Volume Share, by Application (2017-2028)

    • Figure United States Plasma Protease C1-inhibitor Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure United States Plasma Protease C1-inhibitor Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Canada Plasma Protease C1-inhibitor Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Plasma Protease C1-inhibitor Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Plasma Protease C1-inhibitor Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Plasma Protease C1-inhibitor Treatment Sales Value and Growth Rate (2017-2028)

    • Table Europe Plasma Protease C1-inhibitor Treatment Sales Volume, by Type (2017-2028)

    • Table Europe Plasma Protease C1-inhibitor Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Europe Plasma Protease C1-inhibitor Treatment Sales Volume Share, by Type (2017-2028)

    • Table Europe Plasma Protease C1-inhibitor Treatment Sales Volume, by Application (2017-2028)

    • Table Europe Plasma Protease C1-inhibitor Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Europe Plasma Protease C1-inhibitor Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Germany Plasma Protease C1-inhibitor Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Plasma Protease C1-inhibitor Treatment Sales Value and Growth Rate (2017-2028)

    • Figure UK Plasma Protease C1-inhibitor Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure UK Plasma Protease C1-inhibitor Treatment Sales Value and Growth Rate (2017-2028)

    • Figure France Plasma Protease C1-inhibitor Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure France Plasma Protease C1-inhibitor Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Italy Plasma Protease C1-inhibitor Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Plasma Protease C1-inhibitor Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Plasma Protease C1-inhibitor Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Plasma Protease C1-inhibitor Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Spain Plasma Protease C1-inhibitor Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Plasma Protease C1-inhibitor Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Plasma Protease C1-inhibitor Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Plasma Protease C1-inhibitor Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Poland Plasma Protease C1-inhibitor Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Plasma Protease C1-inhibitor Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Russia Plasma Protease C1-inhibitor Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Plasma Protease C1-inhibitor Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Plasma Protease C1-inhibitor Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Plasma Protease C1-inhibitor Treatment Sales Value and Growth Rate (2017-2028)

    • Table APAC Plasma Protease C1-inhibitor Treatment Sales Volume, by Type (2017-2028)

    • Table APAC Plasma Protease C1-inhibitor Treatment Sales Volume Share, by Type (2017-2028)

    • Figure APAC Plasma Protease C1-inhibitor Treatment Sales Volume Share, by Type (2017-2028)

    • Table APAC Plasma Protease C1-inhibitor Treatment Sales Volume, by Application (2017-2028)

    • Table APAC Plasma Protease C1-inhibitor Treatment Sales Volume Share, by Application (2017-2028)

    • Figure APAC Plasma Protease C1-inhibitor Treatment Sales Volume Share, by Application (2017-2028)

    • Figure China Plasma Protease C1-inhibitor Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure China Plasma Protease C1-inhibitor Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Japan Plasma Protease C1-inhibitor Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Plasma Protease C1-inhibitor Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Plasma Protease C1-inhibitor Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Plasma Protease C1-inhibitor Treatment Sales Value and Growth Rate (2017-2028)

    • Figure India Plasma Protease C1-inhibitor Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure India Plasma Protease C1-inhibitor Treatment Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Plasma Protease C1-inhibitor Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Plasma Protease C1-inhibitor Treatment Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Plasma Protease C1-inhibitor Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Plasma Protease C1-inhibitor Treatment Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Plasma Protease C1-inhibitor Treatment Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Plasma Protease C1-inhibitor Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Plasma Protease C1-inhibitor Treatment Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Plasma Protease C1-inhibitor Treatment Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Plasma Protease C1-inhibitor Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Plasma Protease C1-inhibitor Treatment Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Plasma Protease C1-inhibitor Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Plasma Protease C1-inhibitor Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Plasma Protease C1-inhibitor Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Plasma Protease C1-inhibitor Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Plasma Protease C1-inhibitor Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Plasma Protease C1-inhibitor Treatment Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Plasma Protease C1-inhibitor Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Plasma Protease C1-inhibitor Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Plasma Protease C1-inhibitor Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Plasma Protease C1-inhibitor Treatment Sales Value and Growth Rate (2017-2028)

    • Table Takeda Pharmaceutical Company Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Takeda Pharmaceutical Company Limited Product Profiles, Application and Specification

    • Table Takeda Pharmaceutical Company Limited Plasma Protease C1-inhibitor Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table BioCryst Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table BioCryst Pharmaceuticals Product Profiles, Application and Specification

    • Table BioCryst Pharmaceuticals Plasma Protease C1-inhibitor Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ionis Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ionis Pharmaceuticals, Inc Product Profiles, Application and Specification

    • Table Ionis Pharmaceuticals, Inc Plasma Protease C1-inhibitor Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Centogene AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Centogene AG Product Profiles, Application and Specification

    • Table Centogene AG Plasma Protease C1-inhibitor Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table CSL Behring LLC Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table CSL Behring LLC Product Profiles, Application and Specification

    • Table CSL Behring LLC Plasma Protease C1-inhibitor Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table KalVista Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table KalVista Pharmaceuticals, Inc Product Profiles, Application and Specification

    • Table KalVista Pharmaceuticals, Inc Plasma Protease C1-inhibitor Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pharming Technologies BV Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pharming Technologies BV Product Profiles, Application and Specification

    • Table Pharming Technologies BV Plasma Protease C1-inhibitor Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US